Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

7(100.0%)

7Total

N/A(7)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT03525704Not ApplicableCompleted

Evaluation of Contact Lens Saline Solutions With Scleral GP Contact Lens Wearers Experiencing Fogging

Role: lead

NCT04525170Not ApplicableWithdrawn

Clinical Evaluation of HPT Treated Rigid Contact Lenses Made From Hexafocon A

Role: lead

NCT02249689Not ApplicableCompleted

Three-month Clinical Evaluation of Silicone Hydrogel Definitive 65 Contact Lenses

Role: lead

NCT02553681Not ApplicableCompleted

Clinical Evaluation of HPT Treated Rigid Contact Lenses Made From Roflufocon D

Role: lead

NCT01197859Not ApplicableCompleted

Three Month Clinical Evaluation of the Contamac 74% Silicone Hydrogel Contact Lens

Role: lead

NCT02312323Not ApplicableCompleted

One-month Clinical Evaluation of Silicone Hydrogel Definitive 65 HPT Contact Lenses

Role: lead

NCT03612284Not ApplicableCompleted

Scleral Contact Lens Insertion Solution Study

Role: collaborator

All 7 trials loaded